Top Page
Oxford Instruments (OXIG) vs. S&P 500 (SPY)
Oxford Instruments Business Overview & Revenue Model
Oxford Instruments Financial Statement Overview
| Breakdown | ||||
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 470.40M | 444.70M | 367.30M | 318.50M | 317.40M | Gross Profit |
| 242.40M | 219.50M | 176.40M | 153.90M | 146.70M | EBIT |
| 68.30M | 66.70M | 50.80M | 47.40M | 40.70M | EBITDA |
| 93.10M | 94.80M | 67.40M | 71.60M | 58.00M | Net Income Common Stockholders |
| 50.70M | 58.60M | 38.60M | 41.80M | 33.80M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 97.80M | 112.70M | 96.40M | 128.00M | 119.50M | Total Assets |
| 606.30M | 572.00M | 514.00M | 450.70M | 464.00M | Total Debt |
| 47.40M | 43.90M | 28.90M | 37.90M | 60.60M | Net Debt |
| -50.40M | -68.80M | -67.50M | -90.10M | -58.90M | Total Liabilities |
| 240.60M | 228.00M | 197.60M | 184.50M | 212.40M | Stockholders Equity |
| 365.70M | 344.00M | 316.40M | 266.20M | 251.60M |
| Cash Flow | Free Cash Flow | |||
| 14.70M | 34.70M | 34.50M | 36.70M | 48.00M | Operating Cash Flow |
| 42.40M | 67.60M | 49.20M | 41.80M | 55.20M | Investing Cash Flow |
| -37.50M | -37.50M | -45.70M | -4.90M | 14.70M | Financing Cash Flow |
| -18.00M | -16.60M | -15.70M | -30.50M | -11.40M |
Oxford Instruments Technical Analysis
Oxford Instruments Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Neutral | £2.42B | 5.02 | 21.80% | 5.27% | -15.51% | 200.70% | |
66 Neutral | £5.61B | 44.38 | 14.50% | 1.38% | 13.59% | 6.14% | |
65 Neutral | $1.07B | 21.06 | 14.23% | 1.07% | 7.18% | -13.14% | |
59 Neutral | $22.39B | 11.53 | -18.05% | 2.31% | 5.00% | -25.89% | |
56 Neutral | £134.97M | 205.36 | -5.28% | 5.77% | 6.63% | ― |
Oxford Instruments Corporate Events
BlackRock, Inc., a major shareholder in Oxford Instruments PLC, has adjusted its holdings, reducing its total voting rights from 10.94% to 9.97%. This change in holdings, effective as of March 4, 2025, reflects a strategic shift in BlackRock’s investment approach, potentially impacting Oxford Instruments’ shareholder dynamics and market perception.
Artemis Investment Management LLP has increased its voting rights in Oxford Instruments PLC to 11.041235%, up from a previous position of 10.010264%. This change in holdings reflects a strategic move by Artemis, potentially impacting the company’s shareholder dynamics and influencing its future governance and decision-making processes.
Oxford Instruments plc announced the acquisition of partnership and matching shares by its CEO Richard Tyson and CFO Gavin Hill under the company’s Share Incentive Plan. This transaction, conducted on the London Stock Exchange, aligns with the company’s regulatory compliance under the EU Market Abuse Regulation, potentially impacting the company’s governance and stakeholder confidence.
Oxford Instruments announced that as of 28 February 2025, its issued share capital with voting rights consists of 58,093,163 ordinary shares. This figure is crucial for shareholders to determine their notification requirements under the FCA’s Disclosure Guidance and Transparency Rules, impacting how they manage their interests in the company.
Oxford Instruments plc announced the appointment of Rowena Innocent as an Independent Non-Executive Director. Joining the board from February 17, 2025, Innocent will also become a member of several key committees. With over 30 years of experience in high-tech product design and manufacturing, her expertise is expected to significantly enhance the company’s engineering, research, and development pursuits, contributing to its core business objectives.
Oxford Instruments plc announced a transaction involving its Chief Executive Officer Richard Tyson and Chief Financial Officer Gavin Hill, who both acquired Partnership Shares and Matching Shares in the company’s Share Incentive Plan. The transaction, conducted on 10 February 2025 at the London Stock Exchange, reflects the management’s confidence in the company, potentially influencing stakeholder perception positively. The company made this announcement in compliance with the EU Market Abuse Regulation, underscoring its commitment to transparency and regulatory adherence.
Oxford Instruments plc has announced the acquisition of shares by its Chief Executive Officer, Richard Tyson, and Chief Financial Officer, Gavin Hill, as part of the company’s Share Incentive Plan. These transactions, conducted on the London Stock Exchange, signify a strategic move under the EU Market Abuse Regulation, reflecting confidence in the company’s growth and aligning the interests of its top executives with shareholder value.
Oxford Instruments announced a leadership change with the appointment of Paul Fry as the new Chief Financial Officer, succeeding Gavin Hill who will step down at the end of March 2025. Paul Fry brings extensive experience from senior roles in international healthcare and technology companies, which aligns with Oxford Instruments’ growth strategy and commitment to business transformation and innovation.
Oxford Instruments plc announces that Hannah Nichols, their Non-Executive Director and Chair of the Audit and Risk Committee, will transition to Coats Group plc as Group Chief Financial Officer designate and Executive Director on April 24, 2025, taking full CFO responsibilities after Coats Group’s AGM on May 21, 2025. Nichols will be leaving her current position as Group Chief Financial Officer and Executive Director at Hill & Smith PLC by the end of March 2025. This change is part of the company’s compliance with listing regulations, and it may influence Oxford Instruments’ governance and strategic planning.
Oxford Instruments plc announced that as of 31 December 2024, its issued share capital with voting rights comprised 58,047,197 ordinary shares. This information is crucial for shareholders to determine their interests in compliance with the FCA’s Disclosure Guidance and Transparency Rules, thereby impacting how they report their shareholdings.
Oxford Instruments PLC announced a significant change in its shareholder structure, as Artemis Investment Management LLP increased its voting rights in the company to over 10%. This acquisition represents a strategic positioning move, potentially influencing the governance and future strategic decisions of Oxford Instruments, with implications for its stakeholders and market performance.
Oxford Instruments PLC has announced share transactions conducted by its CEO, Richard Tyson, and CFO, Gavin Hill, as part of the company’s Share Incentive Plan. These transactions involve the acquisition of Partnership and Matching Shares on the London Stock Exchange, with details disclosed in compliance with EU Market Abuse Regulation. These actions reflect internal adjustments and compliance measures, potentially reinforcing investor confidence through transparent executive activities.